Menu:
Calcium Blocker
Blogs about Calcium Blocker
- Calcium channel blocker toxicity, acidosis, and GI decontamination ... »
In a letter to the editor responding to the review of calcium channel blocker (CCB) toxicity by Arroyo and Kao, Malcolm George describes a 14yearold patient who developed lactic acidosis (arterial pH 7.08) after overdosing on 5.4 gm ...
- Knockdown of L calcium channel subtypes: differential effects in ... »
Drugs now being developed, such as alpha(2)receptor agonists, the Ntype calcium channel blocker ... Ketamine for treatment of chronic pain: metaanalysis Schmerz Jun 11, 2003 ... (19941996), which have dealt the use of Ketamine for ...
- Buy Norvasc Online Without Prescription »
To Buy Norvasc Online Without Prescription click on link bellow: NORVASC is a type of medicine called a longacting calcium channel blocker (CCB). NORVASC is.
- Should Major Vascular Surgery Be Delayed Because of Preoperative ... »
M. D. Kertai, C. M. Westerhout, K. S. Varga, G. Acsady, and J. Gal Dihydropiridine calciumchannel blockers and perioperative mortality in aortic aneurysm surgery. Br. J. Anaesth., October 1, 2008; 101(4): 458 465. ...
- Learn About Blood Pressure Medications for Treating Hypertension »
These medications include ACE inhibitors, betablockers, diuretics, calcium channel blockers, and angiotensin II receptor blockers. Learn more about these blood pressure medications to better manage your condition.
- Risk for atrial fibrillation varies with different ... »
An epidemiological study found that patients treated for hypertension with betablockers, ACEinhibitors or angiotensin2 receptor blockers (ARBs) had a lower risk of atrial fibrillation (AF) than those treated with calciumchannel ...
Selected News
Forest Laboratories Announces Resignation of Ivan Gergel, MD (The San Francisco Examiner)
NEW YORK, March 19 /PRNewswireFirstCall/ Forest Laboratories, Inc. (NYSE: FRX ) today announced that Ivan Gergel , MD, Senior Vice President Scientific Affairs and President of the Forest Research Institute has resigned his position and will leave the Company effective March 31, 2008 . Read more
Eisai Announces Vasolan(R) (Ischaemic Heart Disease Treatment) Received Approval for Atrial Fibrillation/Flutter and ... (JCN Newswire via Yahoo7 Finance)
Tokyo, Japan, Mar 4, 2008 (JCN Newswire) Eisai Co., Ltd. (TSE: 4523) announced today that Vasolan(R) Tablets 40mg (generic name: verapamil hydrochloride) received approval for the additional indications of the treatment of atrial fibrillation/flutter and paroxysmal supraventricular tachycardia. This approval makes Vasolan the first oral form of calcium channel blockers approved for the ... Read more
26 March 2008 (PharmiWeb)
Tokyo, Japan, Mar 4, 2008 (JCN Newswire) Eisai Co., Ltd. (TSE: 4523) announced today that Vasolan(R) Tablets 40mg (generic name: verapamil hydrochloride) received approval for the additional indications of the treatment of atrial fibrillation/flutter and paroxysmal supraventricular tachycardia. Read more
Related Calcium Blocker Websites
- None yet